Additionally, studies indicated that BRD4 is a known trigger of Runt-related transcription factor 2 (RUNX2), and in some cancer cells, RUNX2 is a direct target of BRD4 inhibition by JQ-1 [64,65,66]. This evidence concerns the gene RUNX2 and cancer.